Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma
The primary tumor cohort showed no association between NY-ESO-1 expression and OS (including stratification by HLA-A∗02 subtype and treatment line) when adjusting for important prognostic factors, possibly due to small sample sizes.
Authors
- Sabine Noal
- Agnes Hernández Biette
- Thibaud Valentin (ORCID: https://orcid.org/0000-0002-3189-8445)
- A. Dufresne
- Laurie Tonon (ORCID: https://orcid.org/0009-0005-8794-7276)
- Nelly Firmin (ORCID: https://orcid.org/0000-0001-5839-6261)
- A. Meurgey
- A. Leroux (ORCID: https://orcid.org/0000-0001-5222-1954)
- Shibani Pokras (ORCID: https://orcid.org/0000-0003-0423-4317)
- Jean‐Yves Blay (ORCID: https://orcid.org/0000-0001-7190-120X)
- Myriam Jean‐Denis (ORCID: https://orcid.org/0000-0002-7885-7421)
- Sylvie Chabaud (ORCID: https://orcid.org/0000-0003-4655-6867)
- Erika Klohe
- Pascale Dubray‐Longeras
- Michael J. Nathenson (ORCID: https://orcid.org/0000-0002-8888-4482)
- Florence Duffaud (ORCID: https://orcid.org/0000-0002-2057-3557)
- Nicolas Gadot (ORCID: https://orcid.org/0000-0002-0457-6272)
- Sophie El Zein (ORCID: https://orcid.org/0000-0001-6630-0020)
- Valéry Attignon (ORCID: https://orcid.org/0000-0002-1529-0595)
- Ioanna Eleftheriadou (ORCID: https://orcid.org/0000-0003-2763-2481)
- Kristin Blouch
- Christophe Delfour (ORCID: https://orcid.org/0000-0002-2387-8145)
- Emmanuelle Bompas (ORCID: https://orcid.org/0000-0003-4414-7760)
- Maud Toulmonde (ORCID: https://orcid.org/0000-0003-3896-9274)
- Gonzague de Pinieux (ORCID: https://orcid.org/0000-0001-5987-4552)
- J. Bollard
- Axel Le Cesne (ORCID: https://orcid.org/0000-0002-8006-8659)
- T. Thayaparan
- Mary Woessner
- Y Robin (ORCID: https://orcid.org/0000-0002-4227-6545)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Université de Tours (FR)
- Inserm (FR)
- Aix-Marseille Université (FR)
- Institut Gustave Roussy (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
- Institut universitaire du cancer de Toulouse Oncopole (FR)
- Institut de Cancérologie de Lorraine (FR)
- Centre François Baclesse (LU)
- Centre Léon Bérard (FR)
- Institut de Cancérologie de l'Ouest (FR)
- Centre Jean Perrin (FR)
- Centre de Recherche en Cancérologie de Lyon (FR)
- Institut Claudius Regaud (FR)
- Centre Oscar Lambret (FR)
- Institut Bergonié (FR)
- Institut de Recherche en Cancérologie de Montpellier (FR)
- Hôpital Saint Eloi (FR)
- Hôpital de la Timone (FR)
- Kalamazoo College (US)
- Institut Curie (FR)
Publication Details
- Journal
- ESMO Open
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1016/j.esmoop.2024.103645
- Citations
- 4
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- GlaxoSmithKline
- Centre Léon Bérard